| HOME >> BIOLOGY >> TECHNOLOGY |
Net income (loss)
per share:
Basic $0.98 $- $(0.21)
Diluted (1) $0.95 $(0.03) $(0.20)
Weighted average
shares outstanding:
Basic 267,276
Diluted (1) 275,522 9,686
FAS 123R GAAP As
Amortization Expense Reported
Income Statement
Classification:
Total revenues $1,100,061
Cost of products
and services sold $(6,514) $(272,313)
Selling, general
and administrative $(22,889) $(318,386)
Research and development $(12,585) $(262,797)
Amortization of
intangibles $(55,658) $(55,658)
Equity in income (loss)
of equity method investments $188
Minority interest $463
Gains (losses) on investments
in equity securities $775
Other $(160)
Investment income $14,870
Interest expense $(1,655)
Summary:
Income (loss) before income
taxes $(55,658) $(41,988) $205,388
(Provision for) benefit
from income taxes $25,957 $12,537 $(60,117)
Net income (loss) $(29,701) $(29,451) $145,271
Net income (loss) per share:
Basic $(0.11) $(0.12) $0.54
<
'/>"/>
| SOURCE Genzyme Corp. Copyright©2008 PR Newswire. All rights reserved |